Silicon-based photonic integrated circuits (PICs) have shown powerful potential as in vitro diagnostic (IVD) tools, offering high sensitivity, multi-omics analysis, multiplexing, precise quantification, and the ability to handle low-volume samples. These advantages are well-documented through commercial efforts and thousands of scientific publications. However, their complexity and high costs have limited their use in home diagnostics.

Luma has pioneered the world’s first fully operational polymeric PICs, achieving optical performance comparable to silicon counterparts—at a fraction of the cost. This breakthrough unlocks the future of affordable, multi-omics testing at home—bringing personalized care and proactive disease management within reach like never before.